Minister for Innovation Opens CSL Biopharmaceutical Formulation Centre and Launches New Victorian Biotechnology Strategy

Minister for Innovation Opens CSL Biopharmaceutical Formulation Centre and Launches New Victorian Biotechnology Strategy

Melbourne, Australia — 15/10/2007

The Hon Gavin Jennings MLC, Victorian Minister for Innovation today officially opened the new Biopharmaceutical Formulation Centre located at CSL Limited in Parkville, Victoria.

The Minister also chose the occasion to launch the new Victorian Government Biotechnology Strategy.

The Centre will be used to formulate quantities of experimental biotechnology medicines under GMP for use in clinical trials, and has been part funded by a Science, Technology and Innovation (STI) Infrastructure grant of $2.7 million from the Victorian Government. CSL has provided a further $5.3 million as well as additional R & D infrastructure and expertise.

The facilities will be used by CSL for their own development projects, by a key partner Swinburne University for the training of students in GMP procedures and to provide a service to small biotechnology companies needing assistance in formulating their own products for testing.

‘This is a wonderful example of how the 2004 Victorian Biotechnology Strategy has resulted in a practical initiative which benefits not only a major company like CSL, but smaller companies who need their products formulated at cost, as well as the academic sector’ CSL Global Head of R & D Dr Andrew Cuthbertson said today.

‘CSL will use the facility to formulate experimental biotechnology medicines that have potential applications in infectious disease and cancer. This represents a critical step in our R & D processes’ he said.

‘We are delighted that the Minister is taking this opportunity to highlight the success of this collaborative venture and launch the 2007 Biotechnology Strategy’.

Organisations requesting further information about using the Centre should contact Dr Jayne Crowley at CSL R & D on 03-9389 1563.

Download this release: PDF icon Minister for Innovation Opens CSL Biopharmaceutical Formulation Centre and Launches New Victorian Biotechnology Strategy

Media Contact
Dr Rachel David
CSL Limited
Director of Public Affairs
Phone: +61 401 775 779
© 2016 CSL Limited